SFO
PFE icon

Stokes Family Office’s Pfizer PFE Stock Holding History

Stokes Family Office’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$473K Sell
19,636
-6,951
-26% -$182K 0.06% 192
2026
Q1 		$747K Sell
26,587
-2,131
-7% -$56.7K 0.08% 154
2025
Q4 		$715K Buy
28,718
+1,589
+6% +$40.1K 0.07% 162
2025
Q3 		$691K Buy
27,129
+1,420
+6% +$35K 0.07% 155
2025
Q2 		$623K Sell
25,709
-45,423
-64% -$1.06M 0.07% 145
2025
Q1 		$1.8M Buy
71,132
+1
+0% +$26 0.2% 89
2024
Q4 		$1.89M Sell
71,131
-4,779
-6% -$130K 0.2% 89
2024
Q3 		$2.2M Buy
75,910
+2,219
+3% +$64.7K 0.24% 76
2024
Q2 		$2.06M Buy
73,691
+466
+0.6% +$12.8K 0.24% 78
2024
Q1 		$2.03M Sell
73,225
-2,033
-3% -$56.4K 0.25% 81
2023
Q4 		$2.17M Sell
75,258
-17,429
-19% -$527K 0.29% 75
2023
Q3 		$3.07M Sell
92,687
-6,906
-7% -$244K 0.36% 68
2023
Q2 		$3.65M Buy
99,593
+1,337
+1% +$52K 0.42% 54
2023
Q1 		$4.01M Sell
98,256
-903
-0.9% -$39K 0.5% 46
2022
Q4 		$5.08M Buy
99,159
+1,170
+1% +$56.1K 0.65% 35
2022
Q3 		$4.29M Sell
97,989
-466
-0.5% -$22.6K 0.61% 36
2022
Q2 		$5.16M Buy
98,455
+1,181
+1% +$60.2K 0.7% 35
2022
Q1 		$5.04M Sell
97,274
-1,312
-1% -$68.1K 0.67% 36
2021
Q4 		$5.82M Buy
98,586
+2,589
+3% +$128K 0.72% 35
2021
Q3 		$4.13M Buy
95,997
+697
+0.7% +$30.9K 0.57% 46
2021
Q2 		$3.73M Sell
95,300
-1,052
-1% -$40.9K 0.53% 46
2021
Q1 		$3.49M Sell
96,352
-2,319
-2% -$82.3K 0.54% 47
2020
Q4 		$3.63M Sell
98,671
-2,992
-3% -$110K 0.72% 38
2020
Q3 		$3.54M Buy
101,663
+1,104
+1% +$38.7K 0.8% 35
2020
Q2 		$3.12M Sell
100,559
-1,049
-1% -$35.6K 0.79% 35
2020
Q1 		$3.15M Buy
101,608
+440
+0.4% +$15K 0.84% 30
2019
Q4 		$3.76M Buy
+101,168
New +$3.6M 0.84% 29

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stokes Family Office's PFE Position: Q2 2026 in Review

Stokes Family Office reduced its Pfizer (PFE) stake by 26% in Q2 2026, selling an estimated $182K and leaving 19,636 shares worth $473K. The position accounts for 0.06% of the portfolio, ranked #192.

Stokes Family Office first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.82M in Q4 2021. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Stokes Family Office held 19,636 shares of Pfizer worth $473K as of Q2 2026.
  • Stokes Family Office sold 6,951 Pfizer shares in Q2 2026, an estimated $182K.
  • Pfizer made up 0.06% of Stokes Family Office's portfolio in Q2 2026, its #192 holding.
  • Stokes Family Office first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Stokes Family Office's Pfizer position peaked at $5.82M in Q4 2021.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Stokes Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.